MRUS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.57%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,392,792.00

Merus Insider Trading History Chart

Merus Share Price & Price History

^$41.73

▼ -1.28 (-2.98%)

As of 04/3/2025 05:00 PM ET

Days: 30 | 90 | 365

Merus Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/27/2024	Peter B. Silverman	COO	Sell	10,000	$60.00	$600,000.00
6/12/2024	Harry Shuman	VP	Sell	7,300	$57.84	$422,232.00	7,002
6/10/2024	Harry Shuman	VP	Sell	1,000	$53.22	$53,220.00	7,002
6/4/2024	Harry Shuman	VP	Sell	6,000	$52.89	$317,340.00	7,002
12/19/2023	Harry Shuman	VP	Sell	115	$26.68	$3,068.20	7,002
12/15/2023	Peter B. Silverman	COO	Sell	22,386	$25.00	$559,650.00
12/1/2023	Harry Shuman	VP	Sell	575	$24.58	$14,133.50	7,367
6/1/2023	Harry Shuman	VP	Sell	575	$21.48	$12,351.00	5,442
12/13/2022	Harry Shuman	VP	Sell	168	$13.85	$2,326.80	3,517
12/1/2022	Harry Shuman	VP	Sell	575	$15.35	$8,826.25	3,685
11/3/2022	Sven Ante Lundberg	CEO	Buy	14,706	$14.38	$211,472.28	40,576
8/25/2022	Harry Shuman	VP	Sell	165	$24.33	$4,014.45	1,760
8/22/2022	Sven Ante Lundberg	CEO	Buy	5,826	$22.92	$133,531.92	25,870
8/19/2022	Sven Ante Lundberg	CEO	Buy	704	$22.99	$16,184.96	20,044
7/12/2022	Sven Ante Lundberg	CEO	Buy	4,340	$22.97	$99,689.80	19,340

See Full Table

SEC Filings (Institutional Ownership Changes) for Merus (NASDAQ:MRUS)

96.14% of Merus stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Merus Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/18/2025	California State Teachers Retirement System	41,149	$1.73M	0.0%	+7.5%	0.060%
2/25/2025	Polar Asset Management Partners Inc.	31,354	$1.32M	0.0%	N/A	0.046%
2/19/2025	GF Fund Management CO. LTD.	1,438	$60K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	98,744	$4.15M	0.0%	+17.3%	0.144%
2/17/2025	VR Adviser LLC	592,411	$24.91M	1.7%	-34.8%	0.865%
2/17/2025	Woodline Partners LP	1,188,518	$49.98M	0.3%	+0.3%	1.736%
2/17/2025	Soleus Capital Management L.P.	312,321	$13.13M	0.8%	-21.6%	0.456%
2/17/2025	Squarepoint Ops LLC	19,440	$0.82M	0.0%	N/A	0.028%
2/17/2025	Wexford Capital LP	40,386	$1.70M	0.3%	+26.2%	0.059%
2/17/2025	Two Sigma Advisers LP	720,800	$30.31M	0.1%	-1.2%	1.053%
2/17/2025	Two Sigma Investments LP	507,741	$21.35M	0.0%	-14.4%	0.742%
2/17/2025	State of Wyoming	1,130	$48K	0.0%	N/A	0.002%
2/17/2025	Stempoint Capital LP	614,812	$25.85M	6.4%	+46.0%	0.898%
2/17/2025	Sphera Funds Management LTD.	130,532	$5.49M	1.0%	-11.6%	0.191%
2/17/2025	Polar Asset Management Partners Inc.	31,354	$1.32M	0.0%	N/A	0.046%
2/17/2025	Polar Capital Holdings Plc	1,706,238	$71.75M	0.4%	+34.7%	2.492%
2/17/2025	Paradigm Biocapital Advisors LP	1,689,922	$71.06M	2.5%	-31.2%	2.468%
2/17/2025	Parkman Healthcare Partners LLC	45,680	$1.92M	0.3%	+0.7%	0.067%
2/17/2025	Nuveen Asset Management LLC	36,422	$1.53M	0.0%	-2.6%	0.053%
2/17/2025	OMERS ADMINISTRATION Corp	10,600	$0.45M	0.0%	N/A	0.015%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	14,540	$0.61M	0.0%	+46.5%	0.021%
2/17/2025	Octagon Capital Advisors LP	308,000	$12.95M	2.1%	N/A	0.450%
2/17/2025	Millennium Management LLC	883,565	$37.15M	0.0%	+87.0%	1.291%
2/17/2025	Lazard Asset Management LLC	2,007	$84K	0.0%	N/A	0.003%
2/17/2025	J. Goldman & Co LP	7,001	$0.29M	0.0%	-82.7%	0.010%
2/17/2025	Janus Henderson Group PLC	21,290	$0.89M	0.0%	+12.7%	0.031%
2/17/2025	Granahan Investment Management LLC	104,562	$4.40M	0.2%	-7.7%	0.153%
2/17/2025	Fred Alger Management LLC	47,288	$1.99M	0.0%	-18.4%	0.069%
2/17/2025	Deutsche Bank AG	113,056	$4.75M	0.0%	+0.4%	0.165%
2/17/2025	D. E. Shaw & Co. Inc.	359,048	$15.10M	0.0%	-45.9%	0.524%
2/17/2025	DAFNA Capital Management LLC	451,804	$19M	4.8%	+9.5%	0.660%
2/17/2025	Deerfield Management Company L.P. Series C	2,972,787	$125.01M	2.4%	-12.8%	4.342%
2/17/2025	Driehaus Capital Management LLC	1,280,337	$53.84M	0.4%	-5.8%	1.870%
2/17/2025	Baker BROS. Advisors LP	450,000	$18.92M	0.2%	+50.0%	0.657%
2/17/2025	Balyasny Asset Management L.P.	33,399	$1.40M	0.0%	-94.4%	0.049%
2/17/2025	Bank of America Corp DE	37,805	$1.59M	0.0%	-40.9%	0.055%
2/17/2025	BNP Paribas Financial Markets	187,548	$7.89M	0.0%	-3.6%	0.274%
2/17/2025	Algert Global LLC	173,114	$7.28M	0.2%	+12.6%	0.253%
2/17/2025	Alyeska Investment Group L.P.	136,364	$5.73M	0.0%	N/A	0.199%
2/17/2025	Allostery Investments LP	21,735	$0.91M	0.9%	N/A	0.032%
2/17/2025	Ally Bridge Group NY LLC	116,796	$4.91M	4.1%	-43.9%	0.171%
2/14/2025	Boxer Capital Management LLC	1,900,000	$79.90M	6.8%	N/A	2.775%
2/14/2025	Novo Holdings A S	750,000	$31.54M	1.9%	+7.1%	1.095%
2/14/2025	Caligan Partners LP	255,000	$10.72M	2.9%	N/A	0.372%
2/14/2025	Northern Trust Corp	76,335	$3.21M	0.0%	+61.2%	0.112%
2/14/2025	The Manufacturers Life Insurance Company	42,085	$1.77M	0.0%	-17.9%	0.061%
2/14/2025	Tudor Investment Corp ET AL	5,075	$0.21M	0.0%	N/A	0.007%
2/14/2025	Public Employees Retirement Association of Colorado	3,482	$0.15M	0.0%	N/A	0.005%
2/14/2025	Artia Global Partners LP	463,840	$19.50M	7.0%	+478.6%	0.678%
2/14/2025	Lynx1 Capital Management LP	1,580,841	$66.47M	24.9%	-11.9%	2.309%
2/14/2025	Tri Locum Partners LP	347,303	$14.60M	3.0%	+80.7%	0.507%
2/14/2025	Aquatic Capital Management LLC	18,247	$0.77M	0.0%	-24.6%	0.027%
2/14/2025	Boothbay Fund Management LLC	80,000	$3.36M	0.1%	N/A	0.117%
2/14/2025	Susquehanna Fundamental Investments LLC	53,938	$2.27M	0.0%	N/A	0.079%
2/14/2025	Nebula Research & Development LLC	31,485	$1.32M	0.2%	+4.9%	0.046%
2/14/2025	Voya Investment Management LLC	62,000	$2.61M	0.0%	+5.8%	0.091%
2/14/2025	Adage Capital Partners GP L.L.C.	250,000	$10.51M	0.0%	+35.1%	0.365%
2/14/2025	T. Rowe Price Investment Management Inc.	808,576	$34M	0.0%	-2.6%	1.181%
2/14/2025	Price T Rowe Associates Inc. MD	1,116,820	$46.96M	0.0%	-12.9%	1.631%
2/14/2025	Silverarc Capital Management LLC	680,845	$28.63M	6.3%	+7.1%	0.995%
2/14/2025	Avoro Capital Advisors LLC	2,125,000	$89.36M	1.3%	+56.8%	3.104%
2/14/2025	Tower Research Capital LLC TRC	2,668	$0.11M	0.0%	-77.6%	0.004%
2/14/2025	Gilead Sciences Inc.	452,527	$19.03M	1.2%	N/A	0.661%
2/13/2025	Marshall Wace LLP	862,089	$36.25M	0.0%	-23.2%	1.259%
2/13/2025	Affinity Asset Advisors LLC	389,241	$16.37M	2.2%	+140.7%	0.569%
2/13/2025	Jump Financial LLC	54,412	$2.29M	0.0%	-27.7%	0.079%
2/13/2025	Capital Fund Management S.A.	10,158	$0.43M	0.0%	N/A	0.015%
2/13/2025	CenterBook Partners LP	142,875	$6.01M	0.4%	+664.0%	0.209%
2/13/2025	Raymond James Financial Inc.	8,231	$0.35M	0.0%	N/A	0.012%
2/13/2025	Legal & General Group Plc	42,758	$1.80M	0.0%	-1.0%	0.062%
2/13/2025	Invesco Ltd.	786,365	$33.07M	0.0%	+2.2%	1.149%
2/13/2025	ADAR1 Capital Management LLC	81,460	$3.43M	0.7%	-46.9%	0.119%
2/13/2025	FMR LLC	6,899,521	$290.13M	0.0%	+0.4%	10.078%
2/13/2025	Federated Hermes Inc.	1,593,375	$67M	0.1%	-20.6%	2.327%
2/13/2025	Springhill Fund Asset Management HK Co Ltd	83,800	$3.52M	5.7%	N/A	0.122%
2/13/2025	Russell Investments Group Ltd.	2,888	$0.12M	0.0%	-10.5%	0.004%
2/13/2025	Rhenman & Partners Asset Management AB	74,500	$3.13M	0.3%	-6.3%	0.109%
2/13/2025	Wells Fargo & Company MN	1,400	$59K	0.0%	+27.3%	0.002%
2/12/2025	Trexquant Investment LP	100,733	$4.24M	0.0%	-8.8%	0.147%
2/12/2025	Geode Capital Management LLC	52,636	$2.21M	0.0%	+1.0%	0.077%
2/12/2025	Franklin Resources Inc.	1,984,538	$83.45M	0.0%	-12.1%	2.899%
2/12/2025	Alliancebernstein L.P.	796,957	$33.51M	0.0%	+9.1%	1.164%
2/12/2025	Wellington Management Group LLP	3,497,653	$147.08M	0.0%	+21.1%	5.062%
2/12/2025	Pictet Asset Management Holding SA	1,031,827	$43.39M	0.0%	+1.9%	1.507%
2/12/2025	NEOS Investment Management LLC	14,491	$0.61M	0.0%	+10.9%	0.021%
2/12/2025	BIT Capital GmbH	21,402	$0.90M	0.1%	+167.5%	0.031%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	5,590	$0.24M	0.0%	-7.1%	0.008%
2/11/2025	KLP Kapitalforvaltning AS	10,300	$0.43M	0.0%	N/A	0.015%
2/11/2025	Teacher Retirement System of Texas	14,152	$0.60M	0.0%	+28.7%	0.021%
2/10/2025	Swiss National Bank	93,954	$3.95M	0.0%	+9.7%	0.137%
2/7/2025	HighTower Advisors LLC	8,020	$0.34M	0.0%	+10.9%	0.012%
2/6/2025	Raymond James Financial Inc.	8,231	$0.35M	0.0%	N/A	0.012%
2/6/2025	Arizona State Retirement System	13,833	$0.58M	0.0%	+9.6%	0.020%
2/5/2025	US Bancorp DE	692	$29K	0.0%	-66.3%	0.001%
2/4/2025	Bank of New York Mellon Corp	36,038	$1.52M	0.0%	-3.3%	0.053%
2/4/2025	Impax Asset Management Group plc	180,000	$7.57M	0.0%	N/A	0.263%
2/4/2025	HealthInvest Partners AB	62,521	$2.62M	1.2%	+23.3%	0.091%
2/3/2025	TimesSquare Capital Management LLC	331,195	$13.93M	0.2%	+21.6%	0.484%
1/31/2025	State of New Jersey Common Pension Fund D	48,268	$2.03M	0.0%	+29.0%	0.071%
1/24/2025	China Universal Asset Management Co. Ltd.	14,517	$0.61M	0.1%	+10.7%	0.021%

Data available starting January 2016

See Full Table

Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer and castration-resistant prostate cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; collaboration with Incyte Corporation for the development of MCLA-145; and collaboration with Gilead Sciences, Inc. to discover novel antibody-based trispecific T-cell engagers. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

Today's Range

Now: $41.73

$41.23

$43.58

50 Day Range

MA: $44.07

$39.60

$49.16

52 Week Range

Now: $41.73

$37.77

$61.61

Volume

918,738 shs

Average Volume

700,656 shs

Market Capitalization

$2.88 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Who are the company insiders with the largest holdings of Merus?: Merus' top insider shareholders include:
Harry Shuman (VP)
Peter B Silverman (COO)
Learn More about top insider investors at Merus.